Clinical Evidence
Improving IV Insulin Administration in a Community Hospital
Setting: 207-bed not-for-profit community hospital.
Objective
This study compares glycemic outcomes with a traditional paper protocol to a computerized glucose management system (EndoTool) for patients receiving intravenous insulin.
Setting
207-bed not-for-profit community hospital.
Results
- Incidence of hypoglycemia <70 mg/dL decreased 89% with EndoTool, from 6.9% to 0.76% of blood glucose readings
- Incidence of hypoglycemia <40 mg/dL was .01% of blood glucose readings with EndoTool.
- Incidence of hyperglycemia >180 mg/dL decreased 54% with EndoTool, from 26.3% to 12.1% of blood glucose readings, and incidence >300 mg/dL decreased 68%, from 4.9% to 1.55% of blood glucose readings.
- Percentage of blood glucose readings in target increased 35% with EndoTool, from 63.6% to 86.1%.
Conclusions
Use of a computerized glucose management system (EndoTool) achieves substantially better glucose control than a traditional paper protocol, with lower incidence of both hypoglycemia and hyperglycemia and a greater percentage of blood glucose readings in target.
References
Authors
Michael Magee.
Source
Published in Journal of Visualized Experiments (Medicine), Issue 64, pe3705.
Year
2012
Related posts
Clinical Evidence
Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment
Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment
The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Clinical Evidence
Achieving Optimal Glucose Control in Critical Care Units at Atrium Health
20 minute read
Achieving Optimal Glucose Control in Critical Care Units at Atrium Health
The objective of this study was to evaluate the impact of different blood glucose (BG) target ranges for IV insulin infusions on inpatient glucose metrics, specifically focusing on hypo and hyperglycemic events, duration of IV insulin therapy, and length of stay (LOS) in the hospital.
Clinical Evidence
Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings
Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings
To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.
Get in Touch
Ready to get started?
Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.
"*" indicates required fields